IN2014MN01759A - - Google Patents

Info

Publication number
IN2014MN01759A
IN2014MN01759A IN1759MUN2014A IN2014MN01759A IN 2014MN01759 A IN2014MN01759 A IN 2014MN01759A IN 1759MUN2014 A IN1759MUN2014 A IN 1759MUN2014A IN 2014MN01759 A IN2014MN01759 A IN 2014MN01759A
Authority
IN
India
Prior art keywords
protein
relates
renal
syndecan
sparc
Prior art date
Application number
Other languages
English (en)
Inventor
Joseph Anderberg
Jeff Gray
Paul Mcpherson
Kevin Nakamura
James Patrick Kampf
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Publication of IN2014MN01759A publication Critical patent/IN2014MN01759A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601—Control or regulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/75—General characteristics of the apparatus with filters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
IN1759MUN2014 2012-02-27 2013-02-27 IN2014MN01759A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261603906P 2012-02-27 2012-02-27
US201261603912P 2012-02-27 2012-02-27
PCT/US2013/028000 WO2013130591A1 (fr) 2012-02-27 2013-02-27 Procédés et compositions pour le diagnostic et le pronostic des lésions rénales et de l'insuffisance rénale

Publications (1)

Publication Number Publication Date
IN2014MN01759A true IN2014MN01759A (fr) 2015-07-03

Family

ID=49083233

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1759MUN2014 IN2014MN01759A (fr) 2012-02-27 2013-02-27

Country Status (9)

Country Link
US (1) US20150010929A1 (fr)
EP (1) EP2820146A4 (fr)
JP (1) JP2015508181A (fr)
CN (1) CN104379758A (fr)
AU (1) AU2013226181A1 (fr)
CA (1) CA2865559A1 (fr)
HK (1) HK1204339A1 (fr)
IN (1) IN2014MN01759A (fr)
WO (1) WO2013130591A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140363834A1 (en) * 2012-01-28 2014-12-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA3012985A1 (fr) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarqueurs de maladies vasculaires
CN107709993A (zh) * 2015-06-11 2018-02-16 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070233391A1 (en) * 2002-03-07 2007-10-04 Cambridge University Technical Service Limited (CUTS) Scd fingerprints
WO2005024603A2 (fr) * 2003-09-10 2005-03-17 The Board Of Regents Of The University Of Texas System Methodes pour detecter, pour diagnostiquer et pour traiter un carcinome cellulaire renal humain
FR2872579B1 (fr) * 2004-06-30 2006-11-24 Pasteur Institut Detection de la tuberculose et de l'infection par mycobacterium tuberculosis a l'aide de hbha
US20090178145A1 (en) * 2005-05-11 2009-07-09 The Procter & Gamble Company Methods and targets for identifying compounds for regulating angiogenesis
US7623910B2 (en) * 2006-03-10 2009-11-24 University Of Rochester ECG-based differentiation of LQT1 and LQT2 mutation
CN104391116B (zh) * 2008-10-21 2016-09-07 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
AU2010210540B2 (en) * 2009-02-06 2015-06-18 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and failure
WO2010128158A1 (fr) * 2009-05-08 2010-11-11 Novartis Ag Biomarqueurs diagnostiques pour des troubles fibrotiques
WO2013096740A1 (fr) * 2011-12-21 2013-06-27 Alere San Diego Inc. Procédés et compositions destinés à attribuer une probabilité de progression de maladie rénale chronique

Also Published As

Publication number Publication date
JP2015508181A (ja) 2015-03-16
CA2865559A1 (fr) 2013-09-06
US20150010929A1 (en) 2015-01-08
EP2820146A1 (fr) 2015-01-07
EP2820146A4 (fr) 2015-12-16
WO2013130591A1 (fr) 2013-09-06
HK1204339A1 (en) 2015-11-13
CN104379758A (zh) 2015-02-25
AU2013226181A1 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
MX341191B (es) Metodos y composiciones para diagnostico y prognosis de lesion renal y falla renal.
EP3070474A3 (fr) Procedes et compositions pour le diagnostic et le pronostic de lesion renale et d'insuffisance renale
IN2014MN00377A (fr)
MX2011008323A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
MX2011002233A (es) Metodos y composiciones para la diagnosis y prognosis de daño renal y falla renal.
NZ619883A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2767833A3 (fr) Procédés et compositions pour le diagnostic et le pronostic de lésion rénale et d'insuffisance rénale
MX2014000283A (es) Metodos y composiciones para diagnóstico y pronóstico de lesión e insuficiencia renal.
EP2585827A4 (fr) Méthodes et compositions pour diagnostiquer et pronostiquer une lésion rénale et une insuffisance rénale
MX2012001559A (es) Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal.
WO2011119934A3 (fr) Procédés et substances pour la détection de tumeurs colorectales
EA201790696A1 (ru) Способы и композиции для диагностики и прогнозирования повреждения почек и почечной недостаточности
MX2019008260A (es) Metodos y composiciones para la evaluacion y tratamiento de lesion renal e insuficiencia renal con base en la medicion del ligando 14 de quimiocina de la porcion c-c.
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EA201291314A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
MX339765B (es) Metodos y composiciones para diagnostico y pronostico de lesion renal y falla renal.
TR201902845T4 (tr) Artritik durumların karakterize edilmesine yönelik bileşimler ve yöntemler.
IN2014MN01759A (fr)
WO2015077382A3 (fr) Test cytologique et moléculaire combiné pour la détection précoce d'adénocarcinome œsophagien
IN2014MN00949A (fr)
BR112016003058A2 (pt) composições e métodos para análise multiplex de ácidos nucleicos nras e braf
MX2012003168A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal.
BR112015021507A2 (pt) métodos e composições para o diagnóstico de pré-eclampsia
IN2014MN01760A (fr)
WO2014066860A3 (fr) Méthodes de pronostic et de traitement du cancer